calliditas.se (CALT) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan

The quarterly EPS growth trend demonstrates the business's scalability potential: following successful tests, drug production costs remain minimal relative to profits. Strategic alliances are accelerating the expansion of orphan drugs, although integration with Asahi Kasei and pricing controls in the US are creating pressure. The value of 48.70 represents the latest metric reading, helping to assess the fundamental strength of Calliditas Therapeutics (CALT).

Calliditas Therapeutics, Inc. (CALT) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan saka 04.07.2022 nganti 28.09.2024

Rincian analitis lan laporan data perusahaan calliditas.se (CALT)

- rega saham lan prakiraan rega para ahli:

Rega saham Calliditas Therapeutics|CALT - Prakiraan gabungan firma investasi

- indikator kapitalisasi pasar:

Nilai pasar Calliditas Therapeutics, Inc.|CALT - Nilai Bisnis

- data kapitalisasi buku:

Nilai Buku saben Saham Calliditas Therapeutics|CALT - Ekuitas Perusahaan|Rasio Kapitalisasi marang Aset Bersih calliditas.se|CALT - Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Total Utang marang Modal Calliditas Therapeutics|CALT - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Calliditas Therapeutics AB|CALT - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Calliditas Therapeutics|CALT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Calliditas Therapeutics|Rasio cepet calliditas.se

- indikator bathi lan kelipatan valuasi:

CALT - Asil keuangan resik|Proyeksi bathi mangsa ngarep Calliditas Therapeutics|CALT - Pangali rega marang bathi|Pangali Forward P/E Calliditas Therapeutics|CALT - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Calliditas|CALT - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) Calliditas Therapeutics|CALT - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan calliditas.se|CALT - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Calliditas Therapeutics

- indikator volume dodolan lan pendapatan:

CALT - Pendapatan dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan calliditas.se|CALT - Kapitalisasi marang volume dodolan|Multiplikator Forward P/S Calliditas Therapeutics AB

Analisis wiwitan perusahaan:Calliditas Therapeutics

Analyzing net income per share dynamics is critical for selecting assets with a high margin of safety. This indicator measures EPS growth rates following 10-Q filings, allowing for an assessment of Calliditas Therapeutics (CALT) expansion efficiency through partnerships with STADA and Everest Medicines, which is clearly reflected in the quarterly EPS growth figure.

Pesaing langsung

TVTX: Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan ARDX|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ProKidney|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan AKBA (Akebia Therapeutics)|Wutah bathi EPS kuartalan TVRD|DMAC - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|unicycive.com - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Rockwell Medical Inc. (RMTI) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|cadrenal.com - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan conduitpharma.com|RNLX: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan ZyVersa Therapeutics (ZVSA)